Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 63 of 110 Updated Nov 17, 2026

IGF-1 LR3

Long R3 IGF-1 · LR3-IGF-1

ANECDOTAL + ANIMAL STUDIES · IGF-1 ANALOG (EXTENDED HALF-LIFE); ANABOLIC

▓ 34 indexed citations across PubMed (15), EuropePMC (19).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

34 citations across 1 tier

Tap any tier to jump to that section of the bibliography.

Background

Long arginine 3-IGF-1, abbreviated as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1). It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence, and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids. The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability. As a result, it is approximately three times more potent than IGF-1, and possesses a significantly longer half-life of about 20–30 hours.

→ Wikipedia

Mechanism of action

IGF-1 receptor agonist; Arg3 substitution reduces IGFBP binding for prolonged activity

Researched effects

Muscle hyperplasia and growth; cellular proliferation; nutrient partitioning

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

20 mcg SC daily (Seeds Vol 1 endurance and recovery starting dose, range up to 100 mcg/day for hypertrophy per r/Peptides wiki)

→ Seeds WA, Peptide Protocols Vol 1 (IGF-1 LR3 endurance/recovery starter); r/Peptides wiki recovery vs hypertrophy dose split

Known concerns

Hypoglycemia risk; theoretical cancer risk; disproportional organ/tissue growth

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.

    American journal of physiology. Endocrinology and metabolism · 2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  2. Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration.

    International journal of biological macromolecules · 2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  3. Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.

    Journal of Alzheimer's disease : JAD · 2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  4. IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained.

    2024 — RESEARCH ARTICLES · AUTHORITY 34.4

  5. Fetal cardiac troponin I levels decline toward birth in sheep.

    2024 — RESEARCH ARTICLES · AUTHORITY 34.4

  6. Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris.

    Applied microbiology and biotechnology · 2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  7. Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets.

    Journal of developmental origins of health and disease · 2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  8. In Vitro and In Vivo Effects of IGF-1 Delivery Strategies on Tendon Healing: A Review.

    2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  9. Signaling Pathways of the Insulin-like Growth Factor Binding Proteins.

    2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  10. N-Linked Glycosylation in Chinese Hamster Ovary Cells Is Critical for Insulin-like Growth Factor 1 Signaling.

    International journal of molecular sciences · 2022 — RESEARCH ARTICLES · AUTHORITY 34.2

Full citation library

Year distribution

Research Articles

34
  1. 1.

    Lu Z, Liu N, Huang H, Wang Y, et al. · Applied microbiology and biotechnology · 2023 · PMID 37261455

    Insulin-like growth factor-1 (IGF-1) is a pleiotropic protein hormone and has become an attractive therapeutic target because of its multiple roles in various physiological processes, including growth, development, and metabolism. However, its production is hindered by low heterogenous protein expression levels in various expression systems and hard to meet the needs of clinical and scientific research. Here, we report that human IGF-1 and its analog Long R3 IGF-1 (LR3 IGF-1) are recombinant exp…

  2. 2.

    White A, Stremming J, Wesolowski SR, Al-Juboori SI, et al. · American journal of physiology. Endocrinology and metabolism · 2025 · PMID 39679943

    Insulin-like growth factor-1 (IGF-1) and insulin are important fetal anabolic hormones. Complications of pregnancy, such as placental insufficiency, can lead to fetal growth restriction (FGR) with low-circulating IGF-1 and insulin concentrations and attenuated glucose-stimulated insulin secretion (GSIS), which likely contribute to neonatal glucose dysregulation. We previously demonstrated that a 1-wk infusion of IGF-1 LR3, an IGF-1 analog with low affinity for IGF-binding proteins and high affin…

  3. 3.

    White A, Stremming J, Brown LD, Rozance PJ · Journal of developmental origins of health and disease · 2023 · PMID 37114757

    Insulin-like growth factor-1 (IGF-1) is a critical fetal growth hormone that has been proposed as a therapy for intrauterine growth restriction. We previously demonstrated that a 1-week IGF-1 LR3 infusion into fetal sheep reduces

  4. 4.

    Stremming J, White A, Donthi A, Batt DG, et al. · Frontiers in physiology · 2022 · PMID 36091374

    IGF-1 is a critical fetal growth-promoting hormone. Experimental infusion of an IGF-1 analog, human recombinant LR3 IGF-1, into late gestation fetal sheep increased fetal organ growth and skeletal muscle myoblast proliferation. However, LR3 IGF-1 has a low affinity for IGF binding proteins (IGFBP), thus reducing physiologic regulation of IGF-1 bioavailability. The peptide sequences for LR3 IGF-1 and sheep IGF-1 also differ. To overcome these limitations with LR3 IGF-1, we developed an ovine (she…

  5. 5.

    Jonker SS, Giraud GD, Chang EI, Elman MR, et al. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020 · PMID 32573852

    As loss of contractile function in heart disease could often be mitigated by increased cardiomyocyte number, expansion of cardiomyocyte endowment paired with increased vascular supply is a desirable therapeutic goal. Insulin-like growth factor 1 (IGF-1) administration increases fetal cardiomyocyte proliferation and heart mass, but how fetal IGF-1 treatment affects coronary growth and function is unknown. Near-term fetal sheep underwent surgical instrumentation and were studied from 127 to 134 d…

  6. 6.

    Yavuz E, Sağır MS, Ercan A, Erginer M, et al. · International journal of biological macromolecules · 2025 · PMID 41015370

    Peripheral nerve injuries lead to significant functional deficits, with no treatment achieving complete recovery. Autologous nerve grafting remains the gold standard, but it is limited by donor site morbidity. Artificial nerve conduits have been developed but have not matched the outcomes of autologous grafts. This study introduces the first-ever decellularized plant-based nerve conduit, fabricated from Alstroemeria stem material, integrated with GelMA, and featuring controlled release of Insuli…

  7. 7.

    Stremming J, Heard S, White A, Chang EI, et al. · American journal of physiology. Endocrinology and metabolism · 2021 · PMID 33427051

    Insulin-like growth factor-1 (IGF-1) is an important fetal growth factor. However, the role of fetal IGF-1 in increasing placental blood flow, nutrient transfer, and nutrient availability to support fetal growth and protein accretion is not well understood. Catheterized fetuses from late gestation pregnant sheep received an intravenous infusion of LR3 IGF-1 (LR3 IGF-1;

  8. 8.

    White A, Stremming J, Boehmer BH, Chang EI, et al. · American journal of physiology. Endocrinology and metabolism · 2021 · PMID 33938236

    Insulin and insulin-like growth factor-1 (IGF-1) are fetal hormones critical to establishing normal fetal growth. Experimentally elevated IGF-1 concentrations during late gestation increase fetal weight but lower fetal plasma insulin concentrations. We therefore hypothesized that infusion of an IGF-1 analog for 1 wk into late gestation fetal sheep would attenuate fetal glucose-stimulated insulin secretion (GSIS) and insulin secretion in islets isolated from these fetuses. Late gestation fetal sh…

  9. 9.

    Salvi R, Kumar C, Brahmbhatt K, Subedi R, et al. · International journal of molecular sciences · 2022 · PMID 36499281

    Cell surface proteins carrying N-glycans play important roles in inter- and intracellular processes including cell adhesion, development, and cellular recognition. Dysregulation of the glycosylation machinery has been implicated in various diseases, and investigation of global differential cell surface proteome effects due to the loss of N-glycosylation will provide comprehensive insights into their pathogenesis. Cell surface proteins isolated from Parent Pro

  10. 10.

    Sundgren NC, Giraud GD, Schultz JM, Lasarev MR, et al. · American journal of physiology. Regulatory, integrative and comparative physiology · 2003 · PMID 12947030

    Growth of the fetal heart involves cardiomyocyte enlargement, division, and maturation. Insulin-like growth factor-1 (IGF-1) is implicated in many aspects of growth and is likely to be important in developmental heart growth. IGF-1 stimulates the IGF-1 receptor (IGF1R) and downstream signaling pathways, including extracellular signal-regulated kinase (ERK) and phosphoinositol-3 kinase (PI3K). We hypothesized that IGF-1 stimulates cardiomyocyte proliferation and enlargement through stimulation of…

  11. 11.

    Engel MG, Narayan S, Cui MH, Branch CA, et al. · Journal of Alzheimer's disease : JAD · 2025 · PMID 39610283

    Insulin-like growth factor-1 (IGF-1) promotes neurogenesis, cell survival, and glial function, making it a promising candidate therapy in Alzheimer's disease (AD). Long arginine 3-IGF-1 (LR3-IGF-1) is a potent IGF-1 analogue. We sought to determine whether intranasal (IN) LR3 treatment would delay cognitive decline and pathology in 5XFAD mice. Wildtype and 5XFAD male mice were treated for 7 months (3-10 months of age), with IN LR3-IGF-1 or IN Vehicle (Veh) (n = 19-27 mice/group). Behavior, memor…

  12. 12.

    Shen Z, Martens H, Schweigel-Röntgen M · Experimental physiology · 2012 · PMID 22227200

    An energy-rich diet leads to enhanced ruminal Na(+) absorption, which is associated with elevated plasma insulin-like growth factor 1 (IGF-1) levels and an increased number of IGF-1 receptors in rumen papillae. This study examined the in vitro effect of IGF-1 on Na(+) transport across the rumen epithelium of hay-fed sheep, in which the IGF-1 concentration in plasma is lower than in concentrate-fed animals. At concentrations ranging from 20 to 100 μg l(-1), serosal LR3-IGF-1, a recombinant analog…

  13. 13.

    Lovell TM, Gladwell RT, Groome NP, Knight PG · Reproduction (Cambridge, England) · 2002 · PMID 11866696

    The aim of this study was to compare the actions and interactions of gonadotrophins (LH and FSH) and an analogue of insulin-like growth factor I (LR3-IGF-I) on the secretion of inhibin A, inhibin B and progesterone by cultured chicken granulosa cells derived from the three largest (F1--F3) follicles of the preovulatory hierarchy. Treatment with LH or FSH promoted marked dose-(P < 0.0001) and time- (P < 0.0001) dependent increases in both inhibin A and progesterone secretion, with the magnitude o…

  14. 14.

    Glister C, Groome NP, Knight PG · Biology of reproduction · 2003 · PMID 12604623

    The objective was to investigate the potential role of the oocyte in modulating proliferation and basal, FSH-induced and insulin-like growth factor (IGF)-induced secretion of inhibin A (inh A), activin A (act A), follistatin (FS), estradiol (E(2)), and progesterone (P(4)) by mural bovine granulosa cells. Cells from 4- to 6-mm follicles were cultured in serum-free medium containing insulin and androstenedione, and the effects of ovine FSH and IGF analogue (LR3-IGF-1) were tested alone and in the…

  15. 15.

    Brankin V, Mitchell MR, Webb B, Hunter MG · Reproductive biology and endocrinology : RB&E · 2003 · PMID 12941156

    Oocyte control of granulosa and theca cell function may be mediated by several growth factors via a local feedback loop(s) between these cell types. This study examined both the role of oocyte-secreted factors on granulosa and thecal cells, cultured independently and in co-culture, and the effect of stem cell factor (SCF); a granulosa cell derived peptide that appears to have multiple roles in follicle development. Granulosa and theca cells were isolated from 2-6 mm healthy follicles of mature p…

  16. 16.

    Stremming J, Chang EI, White A, Rozance PJ, Brown LD. · 2024 · PMID 38727325

    Insulin-like growth factor 1 (IGF-1) is a critical fetal anabolic hormone. IGF-1 infusion to the normally growing sheep fetus increases the weight of some organs but does not consistently increase body weight. However, IGF-1 infusion profoundly decreases fetal plasma insulin concentrations, which may limit fetal growth potential. In this study, normally growing late-gestation fetal sheep received an intravenous infusion of either: IGF-1 (IGF), IGF-1 with insulin and dextrose to maintain fetal eu…

  17. 17.

    Jonker SS, Louey S. · 2024 · PMID 38758126

    Elevated cardiac troponin I (cTnI), a myocardial damage biomarker, has been reported in cord blood of neonates delivered vaginally or by cesarean section. Although the neonatal peak likely reflects the physiological adjustment to extrauterine life, a better understanding of serial prepartum changes is required to determine physiological causes of fetal cTnI release. We longitudinally sampled eight healthy lambs (20 days before spontaneous birth to 5 days postnatal), and from three fetuses receiv…

  18. 18.

    Assefa B, Mahmoud AM, Pfeiffer AFH, Birkenfeld AL, Spranger J, Arafat AM. · 2017 · PMID 29422987

    Insulin-like growth factor binding protein-2 (IGFBP-2) is the predominant IGF binding protein produced during adipogenesis and is known to increase the insulin-stimulated glucose uptake (GU) in myotubes. We investigated the IGFBP-2-induced changes in basal and insulin-stimulated GU in adipocytes and the underlying mechanisms. We further determined the role of insulin and IGF-1 receptors in mediating the IGFBP-2 and the impact of IGFBP-2 on the IGF-1-induced GU. Fully differentiated 3T3-L1 adipoc…

  19. 19.

    Sivasubramaniyam T, Schroer SA, Li A, Luk CT, Shi SY, Besla R, Dodington DW, Metherel AH, Kitson AP, Brunt JJ, Lopes J, Wagner KU, Bazinet RP, Bendeck MP, Robbins CS, Woo M. · 2017 · PMID 28724798

    Atherosclerosis is considered both a metabolic and inflammatory disease; however, the specific tissue and signaling molecules that instigate and propagate this disease remain unclear. The liver is a central site of inflammation and lipid metabolism that is critical for atherosclerosis, and JAK2 is a key mediator of inflammation and, more recently, of hepatic lipid metabolism. However, precise effects of hepatic Jak2 on atherosclerosis remain unknown. We show here that hepatic Jak2 deficiency in…

  20. 20.

    Sarem Z, Bumke-Vogt C, Mahmoud AM, Assefa B, Weickert MO, Adamidou A, Bähr V, Frystyk J, Möhlig M, Spranger J, Lieske S, Birkenfeld AL, Pfeiffer AFH, Arafat AM. · 2017 · PMID 28911141

    <h4>Context</h4>Depending on its lipolytic activity, glucagon plays a promising role in obesity treatment. Glucagon-induced growth hormone (GH) release can promote its effect on lipid metabolism, although the underlying mechanisms have not been well-defined.<h4>Objective</h4>The present study highlights the glucagon effect on the GH/insulinlike growth factor 1 (IGF-1)/IGF-binding protein (IGFBP) axis in vivo and in vitro, taking into consideration insulin as a confounding factor.<h4>Materials an…

  21. 21.

    White A, Louey S, Chang EI, Boehmer BH, Goldstrohm D, Jonker SS, Rozance PJ. · 2018 · PMID 30175552

    Fetal insulin is critical for regulation of growth. Insulin concentrations are partly determined by the amount of β-cells present and their insulin content. Insulin-like growth factor-1 (IGF-1) is a fetal anabolic growth factor which also impacts β-cell mass in models of β-cell injury and diabetes. The extent to which circulating concentrations of IGF-1 impact fetal β-cell mass and pancreatic insulin content is unknown. We hypothesized that an infusion of an IGF-1 analog for 1 week into the late…

  22. 22.

    Steffensen LB, Conover CA, Oxvig C. · 2019 · PMID 31518159

    Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase with a well-established role in releasing bioactive insulin-like growth factor-1 (IGF-1) from IGF-binding protein-2, -4, and -5 by proteolytic processing of these. The IGF system has repeatedly been suggested to be involved in the pathology of atherosclerosis, and both PAPP-A and IGF-1 are proposed biomarkers and therapeutic targets for this disease. Several experimental approaches based on atherosclerosis mouse models have be…

  23. 23.

    Bailes J, Soloviev M. · 2021 · PMID 33557137

    Insulin-like growth factor-1 (IGF-1) is the principal mediator of growth hormone (GH), plays a crucial role in promoting cell growth and differentiation in childhood and continues to have an anabolic effect in adults. IGF-1 is part of a wide network of growth factors, receptors and binding proteins involved in mediating cellular proliferation, differentiation and apoptosis. Bioavailability of IGF-1 is affected by insulin-like growth factor binding proteins (IGFBPs) which bind IGF-1 in circulatio…

  24. 24.

    Thornburg K, Jonker S, O'Tierney P, Chattergoon N, Louey S, Faber J, Giraud G. · 2011 · PMID 21147149

    During fetal life the myocardium expands through replication of cardiomyocytes. In sheep, cardiomyocytes begin the process of becoming terminally differentiated at about 100 gestation days out of 145 days term. In this final step of development, cardiomyocytes become binucleated and stop dividing. The number of cells at birth is important in determining the number of cardiomyocytes for life. Therefore, the regulation of cardiomyocyte growth in the womb is critical to long term disease outcome. G…

  25. 25.

    Brohus M, Gorbunova V, Faulkes CG, Overgaard MT, Conover CA. · 2015 · PMID 26694858

    Naked mole-rats (Heterocephalus glaber) (NMRs) are the longest living rodents known. They show negligible senescence, and are resistant to cancers and certain damaging effects associated with aging. The insulin-like growth factors (IGFs) have pluripotent actions, influencing growth processes in virtually every system of the body. They are established contributors to the aging process, confirmed by the demonstration that decreased IGF signaling results in life-extending effects in a variety of sp…

  26. 26.

    Miescher I, Rieber J, Calcagni M, Buschmann J. · 2023 · PMID 36768692

    Tendon injuries suffer from a slow healing, often ending up in fibrovascular scar formation, leading to inferior mechanical properties and even re-rupture upon resumption of daily work or sports. Strategies including the application of growth factors have been under view for decades. Insulin-like growth factor-1 (IGF-1) is one of the used growth factors and has been applied to tenocyte in vitro cultures as well as in animal preclinical models and to human patients due to its anabolic and matrix…

  27. 27.

    Baxter RC. · 2023 · PMID 36974712

    The 6 high-affinity insulin-like growth factor binding proteins (IGFBPs) are multifunctional proteins that modulate cell signaling through multiple pathways. Their canonical function at the cellular level is to impede access of insulin-like growth factor (IGF)-1 and IGF-2 to their principal receptor IGF1R, but IGFBPs can also inhibit, or sometimes enhance, IGF1R signaling either through their own post-translational modifications, such as phosphorylation or limited proteolysis, or by their intera…

  28. 28.

    Glister C, Satchell L, Michael AE, Bicknell AB, Knight PG. · 2012 · PMID 23152920

    Valproic acid (VPA) is used widely to treat epilepsy and bipolar disorder. Women undergoing VPA treatment reportedly have an increased incidence of polycystic ovarian syndrome (PCOS)-like symptoms including hyperandrogenism and oligo- or amenorrhoea. To investigate potential direct effects of VPA on ovarian steroidogenesis we used primary bovine theca (TC) and granulosa (GC) cells maintained under conditions that preserve their 'follicular' phenotype. Effects of VPA (7.8-500 µg/ml) on TC were te…

  29. 29.

    Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD. · 1996 · PMID 8613530

    The actions of insulin-like growth factor 1 (IGF-1) on protein turnover and of the IGF-1 receptor (IGF-1R) were examined in skeletal muscle of rats with chronic renal failure (CRF) and sham operated (SO), pair-fed controls. Acidemia was prevented in CRF rats with NaHCO3. Serum IGF-1 and skeletal muscle IGF-1 and IGF-1 mRNA were reduced in CRF rats. Dose-response studies revealed impaired stimulation of protein synthesis and suppressed inhibition of protein degradation by IGF-1 in epitrochlearis…

  30. 30.

    Hansen BF, Glendorf T, Hegelund AC, Lundby A, Lützen A, Slaaby R, Stidsen CE. · 2012 · PMID 22590494

    <h4>Aims/hypothesis</h4>There is controversy with respect to molecular characteristics of insulin analogues. We report a series of experiments forming a comprehensive characterisation of the long acting insulin analogues, glargine and detemir, in comparison with human insulin, IGF-1, and the super-mitogenic insulin, X10.<h4>Methods</h4>We measured binding of ligands to membrane-bound and solubilised receptors, receptor activation and mitogenicity in a number of cell types.<h4>Results</h4>Detemir…

  31. 31.

    Aurich K, Glöckl G, Nagel S, Weitschies W. · 2009 · PMID 22408511

    Measurements of magneto-optical relaxation signals of magnetic nanoparticles functionalized with biomolecules are a novel biosensing tool. Upon transmission of a laser beam through a nanoparticle suspension in a pulsed magnetic field, the properties of the laser beam change. This can be detected by optical methods. Biomolecular binding events leading to aggregation of nanoparticles are ascertainable by calculating the relaxation time and from this, the hydrodynamic diameters of the involved part…

  32. 32.

    Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Ballard FJ. · 1993 · PMID 7683875

    The effects of graded doses of insulin-like growth factor-I (IGF-I) and two variants which bind poorly to IGF-binding proteins were investigated in 160 g streptozotocin-induced diabetic rats. The two variants were the truncated form, des(1-3)IGF-I, and another with arginine at residue 3 and an N-terminal extension, termed LR3-IGF-I. The peptides were infused via mini-osmotic pumps. Reference groups received either vehicle or insulin (30 i.u. per day). Treatment led to a marked dose-dependent inc…

  33. 33.

    Tomas FM, Chandler CS, Coyle P, Bourgeois CS, Burgoyne JL, Rofe AM. · 1994 · PMID 8053901

    The effects of insulin-like growth factor-1 (IGF-I), and a more potent variant LR3-IGF-I, which binds poorly to IGF-binding proteins, were investigated in rats bearing a mammary adenocarcinoma. The effect of insulin, either alone or in combination with LR3-IGF-I, was also investigated. Peptides were infused via osmotic minipumps for 6-7 days after tumour size reached 5% of body weight. Infusion of IGFs alone at either 200 or 500 microgram/day significantly decreased food intakes as well as circu…

  34. 34.

    2022 · PMID 35181845

Curated sources on file

2
  1. 1.
  2. 2.

Continue reading